New era of combination therapy for HIV infection Gill Higgins Newsletter Article 05 February 2013 Pages: 3 - 5
G-CSF reduces medical costs in patients undergoing ABMT Newsletter Article 05 February 2013 Pages: 6 - 6
Intermittent omeprazole treatment of choice for GORD? Newsletter Article 05 February 2013 Pages: 7 - 7
Augmenting the effects of antidepressants Kate Palmer Newsletter Article 05 February 2013 Pages: 9 - 10
Promising results with gene therapy for ADA deficiency Newsletter Article 05 February 2013 Pages: 11 - 11
Acellular pertussis vaccine for primary and booster immunisation Newsletter Article 05 February 2013 Pages: 12 - 12
Paediatric fluconazole formulation ‘a considerable advance’ Newsletter Article 05 February 2013 Pages: 12 - 12
Cotrimoxazole prophylactic during multiple myeloma therapy Newsletter Article 05 February 2013 Pages: 13 - 13
Naltrexone promising in repetitive self-injurious behaviour Newsletter Article 05 February 2013 Pages: 13 - 13
Acute phase proteins suppressed by prednisone in Alzheimer’s disease Newsletter Article 05 February 2013 Pages: 14 - 14
Better compliance with 2-month HBV vaccine schedule Newsletter Article 05 February 2013 Pages: 14 - 14
Improving therapy for prostate cancer Lawrence Prescott Newsletter Article 05 February 2013 Pages: 15 - 16
Cookies better than jelly for hypercholesterolaemia? Newsletter Article 05 February 2013 Pages: 16 - 16
Post-discharge LMWH after hip replacement beneficial Newsletter Article 05 February 2013 Pages: 17 - 17
Interferon-α and thymomodulin improve LVEF in cardiomyopathy Newsletter Article 05 February 2013 Pages: 18 - 18
Atenolol less impact on CAD risk than other antihypertensives? Newsletter Article 05 February 2013 Pages: 18 - 18
ACE inhibitors, cerebral blood flow and arterial occlusive disorder Newsletter Article 05 February 2013 Pages: 20 - 20
Phytomenadione and childhood cancer: no association found Newsletter Article 05 February 2013 Pages: 21 - 21